The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix.
Zijlstra
Gerrit S
GS
Department of Pharmaceutical Technology and Biopharmacy, Groningen University Institute for Drug Exploration, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. g.s.zijlstra@farm.rug.nl
Hinrichs
Wouter L J
WL
de Boer
Anne H
AH
Frijlink
Henderik W
HW
D000336:Aerosols; D002626:Chemistry, Pharmaceutical; D004339:Drug Compounding; D005612:Freeze Drying; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000737:chemistry*; D006727:Hormone Antagonists / Q000008:administration & dosage* / Q000737:chemistry*; D008855:Microscopy, Electron, Scanning; D011208:Powders
D000336:Aerosols; D006727:Hormone Antagonists; D011208:Powders; D007987:Gonadotropin-Releasing Hormone; C062876:cetrorelix